YaoGeJu

Company directoryChina company filings

Chongqing Pharscin Pharmaceutical Co., Ltd.

As of 20 November 2026, for the company name Chongqing Pharscin Pharmaceutical Co., Ltd. as recorded, 3 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 43 records, across 30 drug names; since 23 August 2026, the records list Accepted: 2 applications (NMPA data as of 19 November 2026); the chemical-drug catalogue lists 11 active records with this name as holder; 9 active API registrations list this name as first registered company; 9 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

43 acceptance records as first applicant, grouped into 30 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Lercanidipine Hydrochloride Tablets 1 records · Latest accepted 2026/10/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602549Generic2026/10/16Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Clopidogrel Hydrogen Sulphate Tablets 1 records · Latest accepted 2026/09/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601666Supplement2026/09/01Chongqing Pharscin Pharmaceutical Co., Ltd.; Qingdao Huang Hai Pharmaceutical Co., Ltd. romanizedCDE ↗
健儿消食口服液 · No verified English name 3 records · Latest accepted 2026/06/25

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2603000Supplement2026/06/25Chongqing Pharscin Pharmaceutical Co., Ltd.; Henan Ling You Pharma Co., Ltd. romanizedCDE ↗
CYZB2502129Supplement2025/09/25Chongqing Pharscin Pharmaceutical Co., Ltd.; Henan Ling You Pharma Co., Ltd. romanizedCDE ↗
CYZB2501707Supplement2025/08/08Chongqing Pharscin Pharmaceutical Co., Ltd.; Henan Ling You Pharma Co., Ltd. romanizedCDE ↗
Apalutamide Tablets 1 records · Latest accepted 2025/09/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503468Generic2025/09/19Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Orlistat Capsules 2 records · Latest accepted 2025/05/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501687Generic2025/05/09Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYHS2501686Generic2025/05/09Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CX001缓释片 · No verified English name 3 records · Latest accepted 2025/04/17

New drug · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2500394New drug2025/04/17Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CXHL2500393New drug2025/04/17Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CXHL2500392New drug2025/04/17Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
螺旋藻胶囊 · No verified English name 1 records · Latest accepted 2024/12/03

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2402383Supplement2024/12/03Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
上清片 · No verified English name 1 records · Latest accepted 2024/11/26

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2402306Supplement2024/11/26Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Buspirone Hydrochloride Tablets 2 records · Latest accepted 2024/10/13

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403446Generic2024/10/13Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYHS2403445Generic2024/10/13Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Vonoprazan Fumarate Tablets 4 records · Latest accepted 2024/09/05

Supplement · 2Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401388Supplement2024/09/05Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYHB2401387Supplement2024/09/05Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYHS2200908Generic2022/06/20Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYHS2200907Generic2022/06/20Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
苍耳子鼻炎胶囊 · No verified English name 2 records · Latest accepted 2024/09/03

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401663Supplement2024/09/03Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYZB2200522Supplement2022/05/31Chongqing Pharscin Pharmaceutical Co., Ltd.; Hainan Yi Er Pharma Co., Ltd. romanizedCDE ↗
Crizotinib Capsules 1 records · Latest accepted 2024/05/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401414Generic2024/05/11Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
托吡酯口服溶液 · No verified English name 1 records · Latest accepted 2024/03/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400730Generic2024/03/01Chongqing Pharscin Pharmaceutical Co., Ltd.; Huayi Pharmaceuticals (Anhui) Co., Ltd.CDE ↗
Ruxolitinib Phosphate Tablets 1 records · Latest accepted 2024/01/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400363Generic2024/01/27Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
小儿咽扁颗粒 · No verified English name 2 records · Latest accepted 2023/07/31

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2301406Supplement2023/07/31Chongqing Pharscin Pharmaceutical Co., Ltd.; Shanxi Mai Di Pharmaceutical Co., Ltd. romanizedCDE ↗
CYZB2301405Supplement2023/07/31Chongqing Pharscin Pharmaceutical Co., Ltd.; Shanxi Mai Di Pharmaceutical Co., Ltd. romanizedCDE ↗
Agomelatine Tablets 1 records · Latest accepted 2023/07/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301877Generic2023/07/12Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
八味芪龙颗粒 · No verified English name 1 records · Latest accepted 2023/06/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2301195Supplement2023/06/29Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
平消片 · No verified English name 2 records · Latest accepted 2023/06/29

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2301197Supplement2023/06/29Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYZB2101671Supplement2021/09/23Chongqing Pharscin Pharmaceutical Co., Ltd.; Liaoning Yi Bang Pharmaceutical Co., Ltd. romanizedCDE ↗
胆舒软胶囊 · No verified English name 1 records · Latest accepted 2023/06/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2301196Supplement2023/06/29Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Penehyclidine Hydrochloride Injection 1 records · Latest accepted 2023/06/05

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2340013Supplement2023/06/05Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
痛泻宁颗粒 · No verified English name 1 records · Latest accepted 2023/03/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2300470Supplement2023/03/15Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
甘桔冰梅片 · No verified English name 1 records · Latest accepted 2023/03/07

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2300431Supplement2023/03/07Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Olmesartan Medoxomil and Amlodipine Besylate Tablets 1 records · Latest accepted 2023/02/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2300201Supplement2023/02/02Chongqing Pharscin Pharmaceutical Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
Rasagiline Mesylate Tablets 2 records · Latest accepted 2022/06/14

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200878Generic2022/06/14Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
CYHS2200877Generic2022/06/14Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
复方聚乙二醇电解质散(III) · No verified English name 1 records · Latest accepted 2022/05/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200711Generic2022/05/07Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
注射用奥美拉唑钠(静脉滴注) · No verified English name 1 records · Latest accepted 2022/04/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250206Supplement2022/04/12Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
茶愈胶囊 · No verified English name 1 records · Latest accepted 2021/09/23

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2101840Supplement2021/09/23Chongqing Pharscin Pharmaceutical Co., Ltd.; Liaoning Yi Bang Pharmaceutical Co., Ltd. romanizedCDE ↗
Omeprazole and Sodium Bicarbonate Capsules 1 records · Latest accepted 2021/09/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2101843Supplement2021/09/16Chongqing Pharscin Pharmaceutical Co., Ltd.; Beijing Bai Ao Pharma Co., Ltd. romanizedCDE ↗
Gabexate Mesilate For Injection 1 records · Latest accepted 2021/09/14

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150867Supplement2021/09/14Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
盐酸特拉唑嗪胶囊 · No verified English name 1 records · Latest accepted 2021/01/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150081Supplement2021/01/29Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

2 events from 2026/08/23 to 2026/11/20. CDE data as of 2026/11/20; NMPA data as of 2026/11/19.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 2 applications

  1. 2026/10/16Accepted

    Lercanidipine Hydrochloride Tablets

    CYHS2602549

    Fact date: 2026/10/16 · Date added to this site: 2026/10/22

    View source ↗
  2. 2026/09/01Accepted

    Clopidogrel Hydrogen Sulphate Tablets

    CYHB2601666

    Fact date: 2026/09/01 · Date added to this site: 2026/10/22

    View source ↗

Under review

3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Lercanidipine Hydrochloride Tablets CYHS2602549Generic2026/10/16Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Apalutamide Tablets CYHS2503468Generic2025/09/19Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Ruxolitinib Phosphate Tablets CYHS2400363Generic2024/01/27Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

11 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
Buspirone Hydrochloride TabletsChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H202636742026/03/17Generic approved under the new chemical-drug registration classificationCDE ↗
Buspirone Hydrochloride TabletsChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H202636752026/03/17Generic approved under the new chemical-drug registration classificationCDE ↗
Rasagiline Mesylate TabletsChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H202430812024/01/23Generic approved under the new chemical-drug registration classificationCDE ↗
Penehyclidine Hydrochloride InjectionChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H201932712024/01/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
复方聚乙二醇电解质散(III) · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H202344002023/10/27Generic approved under the new chemical-drug registration classificationCDE ↗
Omeprazole Sodium for InjectionChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H201630612023/04/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Omeprazole Sodium for InjectionChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H201630612023/04/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Gabexate Mesilate For InjectionChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H201532282022/08/01Drug that passed quality-and-efficacy consistency evaluationCDE ↗
盐酸特拉唑嗪胶囊 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H109801272022/03/08Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Vonoprazan Fumarate TabletsChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H202438782024/06/04Generic approved under the new chemical-drug registration classificationCDE ↗
Vonoprazan Fumarate TabletsChongqing Pharscin Pharmaceutical Co., Ltd.Chongqing Pharscin Pharmaceutical Co., Ltd.国药准字H202438792024/06/04Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

9 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
阿戈美拉汀 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20230000351A2024/11/20CDE ↗
甲磺酸雷沙吉兰 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20220000136A2023/12/28CDE ↗
铝碳酸镁 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20190009445A2024/10/09CDE ↗
聚维酮碘 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20190008078A2025/09/24CDE ↗
甘草酸二铵 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20190007988A2025/09/02CDE ↗
甲磺酸加贝酯 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20190006610A2026/02/05CDE ↗
阿魏酸钠 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20190001543A—CDE ↗
铝碳酸镁 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20180001477A2024/06/21CDE ↗
盐酸戊乙奎醚 · No verified English nameChongqing Pharscin Pharmaceutical Co., Ltd.Y20170001628A2024/08/07CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

9 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Buspirone Hydrochloride Tablets CYHB2601647Supplement2026/08/27Yuan Da Pharmaceuticals (Xian) Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Buspirone Hydrochloride Tablets CYHB2601646Supplement2026/08/27Yuan Da Pharmaceuticals (Xian) Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Orlistat Capsules CYHB2601547Supplement2026/08/13Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Orlistat Capsules CYHB2500485Supplement2025/03/08Chongqing Xing Chuang Pharmaceuticals Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Empagliflozin Tablets CYHS2401721Generic2024/06/07You Hua Pharmaceuticals Technology Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
Empagliflozin Tablets CYHS2401720Generic2024/06/07You Hua Pharmaceuticals Technology Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
二甲双胍恩格列净片(VI) · No verified English name CYHS2302607Generic2023/09/27Chongqing Xi Wei Pharmaceuticals Technology Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
二甲双胍恩格列净片(I) · No verified English name CYHS2302606Generic2023/09/27Chongqing Xi Wei Pharmaceuticals Technology Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗
孟鲁司特钠颗粒 · No verified English name CYHS2201053Generic2022/07/12You Hua Pharmaceuticals Technology Co., Ltd. romanized; Chongqing Pharscin Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.